Did you know #lenacapavir only requires 2 injections per year to prevent HIV? Did you know its manufacturer @gilead.com is withholding it from middle-income countries where HIV is on the rise, including ones that participated in clinical trials and paved the way for the drug’s approval?
📰 The UK's largest ever real-world study into RSV vaccination has confirmed that babies born to vaccinated mothers are up to 85% less likely to end up in hospital with an RSV chest infection. Thanks to all the NHS health professionals who deliver this vital programme 👏
“We call on countries and the WHO to demand pharmaceutical corporations make these key diabetes treatments available in-country by immediately registering them and – critically – making them affordable.” msfaccess.org/msf-responds...
MSF responds to inclusion of rapid-acting insulin analogues and GLP-1s to WHO Essential Medicines List
MSF welcomes inclusion of key diabetes medicines to WHO EML, and calls for countries and WHO to demand corporations make them available and affordable.
msfaccess.org
Insulin pens must be affordable and available for all people with #diabetes who need them. Why? For many people with diabetes, using pens to administer insulin is easier, more accurate, and preferred over more difficult-to-use vials and syringes.
Hey @novonordisk.bsky.social, all #insulin pens must be available at $1 per pen, so that everyone can access the highest standard of diabetes treatment, especially as their cost of production is estimated to be as low as $0.94 per pen, including a profit.
We welcome the news that @novonordisk.bsky.social will supply South Africa with analogue insulin pens, BUT... The price Novo Nordisk is charging is TOO HIGH at $3.95 per pen. msfaccess.org/msf-welcomes...
MSF welcomes Novo Nordisk’s commitment to supply South Africa with analogue insulin pens, but the price must come down to $1 per pen
Novo Nordisk starts supply of analogue insulin pens to South Africa but price remains high still. All insulin pens must be available at $1 per pen.
msfaccess.org
Time and again, Big Pharma has contested experts-backed generic price studies. Today’s drop in Bedaquiline’s price ($90), bringing it closer to its targeted generic price, is a proof that Pharmaceutical companies must stop profiteering off people's lives.
👇 #IDSky take note @thelancetinfdis.bsky.social has entered the conversation
The Lancet Infectious Diseases is on Bluesky now! Have we missed anything? Quiet time of the year, isn't it... 👉 Follow us for the newest research and commentary in infectious diseases! #IDSky
www.afro.who.int/countries/ug...
WHO accelerates efforts to support response to Sudan virus disease outbreak in Uganda
Brazzaville/Kampala – Following the confirmation of an outbreak of Sudan virus disease – which belongs to the same family as Ebola virus disease – in Uganda today, World Health Organization (WHO) is m...
afro.who.int